BRAIN.Q Launches Israel's First Home Clinic for Stroke Recovery

BRAIN.Q, an Israeli health-tech company, has launched Israel's first home clinic dedicated to stroke recovery, utilizing an AI-based electromagnetic therapy system. This initiative follows the system's regulatory approvals, including Breakthrough Device designation from the United States Food and Drug Administration (FDA), CE Mark certification in the European Union, and AMAR approval from Israel’s Health Ministry. The launch coincides with new clinical findings presented at the International Stroke Conference and the appointment of Professor Jeffrey L. Saver from UCLA as the company’s medical director.

The Jerusalem Post

Strokes are the leading cause of long-term disability in Israel, with approximately 18,400 new cases reported annually and over 100,000 stroke survivors in the country, according to the 2024 State Comptroller’s report. BRAIN.Q's treatment combines a wearable helmet that delivers low-intensity, frequency-tuned electromagnetic stimulation with a personalized rehabilitation program managed through a cloud-based AI platform. A meta-analysis presented at the American Heart Association’s International Stroke Congress indicated that 34% of patients with moderate-to-severe disability achieved full functional independence within months of starting treatment, compared to only 12% in the control group. Furthermore, around 85% of treated patients demonstrated measurable improvement, with the clinical model validated through trials at 15 leading medical centers, including those affiliated with Harvard and UCLA.

The Jerusalem Post

BRAIN.Q distinguishes itself from competitors such as Flow Neuroscience and Neuroelectrics by offering a fully integrated home clinic model that includes a subscription-based service and real-time remote monitoring. The founders assert that this approach could significantly enhance patient adherence and treatment outcomes, addressing a critical gap in long-term brain recovery.

The Jerusalem Post

Yotam Drechsler, BRAIN.Q’s co-founder and CEO, emphasized the importance of brain health, stating that the brain is “our most precious resource.” Professor Saver remarked on Israel's advanced medical ecosystem, noting, “After years of dramatic progress in acute stroke care, long-term brain recovery remains the missing link in global healthcare.”

The Jerusalem Post

While BRAIN.Q's innovative approach has garnered attention, some experts in the field express caution regarding the long-term efficacy and accessibility of such home-based therapies. Concerns have been raised about the potential for disparities in access to technology and the need for comprehensive follow-up care.

The Jerusalem Post

• “Israel is one of the world’s most advanced medical and scientific ecosystems, making it the natural choice to launch such a groundbreaking model. After years of dramatic progress in acute stroke care, long-term brain recovery remains the missing link in global healthcare.” — Professor Jeffrey L. Saver, Medical Director, BRAIN.Q

The Jerusalem Post

• “our most precious resource” — Yotam Drechsler, Co-founder and CEO, BRAIN.Q

The Jerusalem Post

As BRAIN.Q continues to roll out its home clinic model, the company plans to monitor patient outcomes closely and may expand its services based on initial feedback and clinical results. The ongoing research and development in the field of non-invasive neuro-recovery technologies will likely influence future innovations in stroke rehabilitation.

The Jerusalem Post